Tech Company Financing Transactions
Microbion Funding Round
Microbion, based in Bozeman, secured $25 million from GF Private Equity Group and Quark Venture.
Transaction Overview
Company Name
Announced On
1/7/2017
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Undisclosed
Investors
Quark Venture (Karimah Sabar)
Proceeds Purpose
Among other advancements, this investment will enable Microbion to initiate and complete a Phase 1B/2A study in diabetic foot ulcer infections evaluating both safety and efficacy endpoints including eradication of infections and of biofilms.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5 West Mendenhall St. 202
Bozeman, MT 59715
USA
Bozeman, MT 59715
USA
Phone
Website
Email Address
Overview
Microbion is committed to the development of safe, effective approaches to the prevention and treatment of infectious diseases by virtue of the broad-spectrum antimicrobial and antibiofilm properties of our bismuth-thiol (BT) platform technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Karim Lalji
President
Brett Baker
VP - Bus. Development
Guy Cipriani
VP - Engineering
Jeffrey Millard
VP - Operations
Edmond Lee
Browse more venture capital transactions:
Prev: 1/7/2017: RxREVU venture capital transaction
Next: 1/7/2017: MatriSys Bioscience venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs